chr6-129599316-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_033515.3(ARHGAP18):c.1613C>T(p.Thr538Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000177 in 1,583,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_033515.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 4AN: 150858Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000427 AC: 10AN: 233940Hom.: 0 AF XY: 0.0000472 AC XY: 6AN XY: 127000
GnomAD4 exome AF: 0.0000168 AC: 24AN: 1432170Hom.: 0 Cov.: 30 AF XY: 0.0000197 AC XY: 14AN XY: 712264
GnomAD4 genome AF: 0.0000265 AC: 4AN: 150858Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73524
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2024 | The c.1613C>T (p.T538M) alteration is located in exon 12 (coding exon 12) of the ARHGAP18 gene. This alteration results from a C to T substitution at nucleotide position 1613, causing the threonine (T) at amino acid position 538 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at